FarmPharma receives a grant of SEK 300,000

FarmPharma AB (publ), which is a subsidiary of Double Bond Pharmaceutical International AB (publ), have been granted SEK 300,000 by Vinnova in the call “Innovative Startups step 1”. The grant will support ongoing collaboration with Karolinska Institute for the production of starting materials for the company’s drug candidate InterferOX.

More about collaboration with Karolinska Institutet: link

More about Vinnova: link

Share this post